arrow
S

Stephanie Korn

goethe university frankfurt hospital
H指数:43
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of newly initiated biologic therapy on the dose of ICS therapy - Data from the German Asthma Net

新生物制剂疗法对吸入性糖皮质激素疗法剂量的影响——德国哮喘网数据

2026-09-230
PRE
Documentation of biological treatment in asthma

哮喘的生物治疗记录

2026-01-010
PRE
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial

口服皮质类固醇减量和停药在经tezepelumab(WAYFINDER)治疗的皮质类固醇依赖性、重度、未控制哮喘成人中的应用(WAYFINDER):一项多中心、单臂、3b期试验

2025-11-260
OAAI
Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC
2024-10-300
PRE
Tezepelumab in patients with allergic and eosinophilic asthma

Tezepelumab在过敏性和嗜酸性哮喘患者中的应用

2023-12-267
OA